Editorial
Published on 26 Sep 2022
Editorial: Machine learning in radiation oncology
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1032858
- 2,324 views
- 1 citation
- Frontiers in Oncology
- Radiation Oncology
- Articles
Type at least 3 characters
2,072 articles
Articles
Review
Published on 23 Sep 2022
Mechanisms of FLASH effect
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.995612
- 8,680 views
- 22 citations
Original Research
Published on 23 Sep 2022
MRI radiomics-based machine learning model integrated with clinic-radiological features for preoperative differentiation of sinonasal inverted papilloma and malignant sinonasal tumors
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1003639
- 1,502 views
- 2 citations
Review
Published on 23 Sep 2022
Functional lung imaging in thoracic tumor radiotherapy: Application and progress
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.908345
- 2,987 views
- 5 citations
Original Research
Published on 20 Sep 2022
CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.947439
- 2,942 views
- 8 citations
Case Report
Published on 16 Sep 2022
Promising clinical outcome after body gamma knife radiotherapy for mediastinal follicular dendritic cell sarcoma with thoracic spine invasion and iliac metastasis: A case report and literature review
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.919644
- 2,447 views
- 2 citations
Review
Published on 16 Sep 2022
Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.940127
- 3,353 views
- 5 citations
Original Research
Published on 15 Sep 2022
Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1009089
- 2,374 views
- 9 citations
Original Research
Published on 15 Sep 2022
Radiation therapy for de novo anorectal cancer in patients with a history of prostate radiation therapy
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975519
- 2,364 views
- 2 citations
Original Research
Published on 15 Sep 2022
A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.905222
- 2,946 views
- 7 citations
Original Research
Published on 14 Sep 2022
No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.897476
- 1,671 views
- 1 citation
Original Research
Published on 14 Sep 2022
Assessment of quantitative information for radiation therapy at a first-generation clinical photon-counting computed tomography scanner
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.970299
- 2,546 views
- 8 citations
Original Research
Published on 14 Sep 2022
Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.992358
- 1,740 views
- 3 citations
Mini Review
Published on 14 Sep 2022
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.976143
- 1,562 views
- 1 citation
Original Research
Published on 13 Sep 2022
Lymph node metastasis is not associated with survival in patients with clinical stage T4 esophageal squamous cell carcinoma undergoing definitive radiotherapy or chemoradiotherapy
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.774816
- 1,422 views
- 1 citation
Clinical Trial
Published on 09 Sep 2022
Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.880053
- 1,857 views
- 1 citation